Chernyak Victoria, Flusberg Milana, Law Amy, Kobi Mariya, Paroder Viktoriya, Rozenblit Alla M
From the Department of Radiology, Montefiore Medical Center, Bronx, NY.
J Comput Assist Tomogr. 2018 Jan/Feb;42(1):155-161. doi: 10.1097/RCT.0000000000000642.
The goal of this study was to compare agreement between computed tomography (CT) and magnetic resonance imaging (MRI) in the evaluation of the major Liver Imaging Reporting and Data System (LI-RADS) features used in assessment of hepatocellular carcinoma: arterial phase hyperenhancement (APHE), portal venous phase washout (WO), capsule appearance (capsule), and largest diameter (diameter).
Patients with liver protocol CT and gadoxetate-enhanced MRI within 1 month of each other and at least 1 discrete untreated liver lesion were included. Two readers independently reviewed hepatic arterial phase and portal venous phase of each lesion on both CT and MRI, presented at random. The APHE, WO, capsule, and diameter were assessed for each lesion on CT and MRI. The LI-RADS category was assigned based on the recorded major features. Interobserver agreements between the readers for both imaging modalities and for each of the major features were assessed using κ statistics. Agreement between CT and MRI for each reader and for each feature was assessed using κ statistics. Agreement was interpreted based on κ as follows: 0.20 or less, slight agreement; 0.21 to 0.40, fair agreement; 0.41 to 0.60, moderate agreement; 0.61 to 0.80, substantial agreement; and 0.81 to 1.00, almost perfect agreement. Intraclass correlation coefficient was used to assess concordance of diameter measurements.
There were 42 patients (mean age, 62.2 ± 7.0 years; 33 men [78.6%]) with 50 lesions. On CT, the interobserver agreement between the readers was almost perfect for APHE (κ = 0.85), WO (κ = 0.83), and capsule (κ = 0.86). On MRI, the interobserver agreement between the readers was almost perfect for APHE (κ = 0.86) and WO (κ = 0.83) and moderate for capsule (κ = 0.59). Intraclass correlation coefficient for diameter measurement was 0.99 for CT and 0.98 for MRI. For reader 1, the agreement between CT and MRI was fair for APHE (κ = 0.39) and capsule (κ = 0.26) and moderate for WO (κ = 0.49). For reader 2, the agreement between CT and MRI was moderate for APHE (κ = 0.43) and capsule (κ = 0.43) and fair (κ = 0.38) for WO. Agreement between readers for final LI-RADS category was substantial for CT (κ = 0.79) and moderate for MRI (κ = 0.60). Agreement for final LI-RADS categories between MRI and CT was fair for both reader 1 (κ = 0.33) and reader 2 (κ = 0.39).
Interobserver agreement for the major LI-RADS features varies from moderate to almost perfect, for both CT and MRI. However, the agreement between CT and MRI for each of the major LI-RADS features is poor, ranging from fair to moderate. This poor agreement contributes to substantial differences between final LI-RADS category assigned on CT versus MRI.
本研究的目的是比较计算机断层扫描(CT)和磁共振成像(MRI)在评估肝细胞癌时使用的主要肝脏影像报告和数据系统(LI-RADS)特征方面的一致性,这些特征包括动脉期高增强(APHE)、门静脉期洗脱(WO)、包膜表现(capsule)和最大直径(diameter)。
纳入在1个月内先后进行肝脏CT和钆塞酸增强MRI检查且至少有1个未治疗的离散肝脏病变的患者。两名阅片者独立随机审阅CT和MRI上每个病变的肝动脉期和门静脉期图像。对CT和MRI上的每个病变评估APHE、WO、capsule和直径。根据记录的主要特征指定LI-RADS类别。使用κ统计量评估阅片者之间在两种成像方式以及每个主要特征方面的观察者间一致性。使用κ统计量评估每位阅片者以及每个特征在CT和MRI之间的一致性。根据κ值对一致性进行如下解释:0.20及以下为轻微一致;0.21至0.40为一般一致;0.41至0.60为中度一致;0.61至0.80为高度一致;0.81至1.00为几乎完全一致。组内相关系数用于评估直径测量的一致性。
42例患者(平均年龄62.2±7.0岁;33例男性[78.6%])有50个病变。在CT上,阅片者之间对于APHE(κ=0.85)、WO(κ=0.83)和capsule(κ=0.86)的观察者间一致性几乎完全一致。在MRI上,阅片者之间对于APHE(κ=0.86)和WO(κ=0.83)的观察者间一致性几乎完全一致,对于capsule的一致性为中度(κ=0.59)。CT和MRI的直径测量组内相关系数分别为0.99和0.98。对于阅片者1,CT和MRI之间对于APHE(κ=0.39)和capsule(κ=0.26)的一致性为一般,对于WO的一致性为中度(κ=0.49)。对于阅片者2,CT和MRI之间对于APHE(κ=0.43)和capsule(κ=0.43)的一致性为中度,对于WO的一致性为一般(κ=0.38)。阅片者之间对于最终LI-RADS类别在CT上的一致性为高度(κ=0.79),在MRI上为中度(κ=0.60)。阅片者1和阅片者2在MRI和CT之间对于最终LI-RADS类别的一致性均为一般(阅片者1:κ=0.33;阅片者2:κ=0.39)。
对于CT和MRI,观察者间在主要LI-RADS特征方面的一致性从中度到几乎完全一致不等。然而,CT和MRI在每个主要LI-RADS特征方面的一致性较差,从一般到中度不等。这种较差一致性导致CT和MRI分配的最终LI-RADS类别之间存在显著差异。